BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 29653697)

  • 1. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.
    Xu M; Lu H; Lee YH; Wu Y; Liu K; Shi Y; An H; Zhang J; Wang X; Lai Y; Dong C
    Immunity; 2018 Apr; 48(4):787-798.e4. PubMed ID: 29653697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation.
    Su Y; Huang J; Zhao X; Lu H; Wang W; Yang XO; Shi Y; Wang X; Lai Y; Dong C
    Sci Immunol; 2019 Jun; 4(36):. PubMed ID: 31175175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
    Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
    Front Immunol; 2021; 12():635076. PubMed ID: 34025642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
    van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
    J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial TRAF6 drives IL-17-mediated psoriatic inflammation.
    Matsumoto R; Dainichi T; Tsuchiya S; Nomura T; Kitoh A; Hayden MS; Ishii KJ; Tanaka M; Honda T; Egawa G; Otsuka A; Nakajima S; Sakurai K; Nakano Y; Kobayashi T; Sugimoto Y; Kabashima K
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation.
    Martin JC; Wolk K; Bériou G; Abidi A; Witte-Händel E; Louvet C; Kokolakis G; Drujont L; Dumoutier L; Renauld JC; Sabat R; Josien R
    J Immunol; 2017 May; 198(9):3671-3678. PubMed ID: 28356382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratinocyte-Derived IL-17E Contributes to Inflammation in Psoriasis.
    Senra L; Stalder R; Alvarez Martinez D; Chizzolini C; Boehncke WH; Brembilla NC
    J Invest Dermatol; 2016 Oct; 136(10):1970-1980. PubMed ID: 27329229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis.
    Chen HL; Lo CH; Huang CC; Lu MP; Hu PY; Chen CS; Chueh DY; Chen P; Lin TN; Lo YH; Hsiao YP; Hsu DK; Liu FT
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33055419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
    El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A
    J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
    Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin Downregulates Psoriatic Inflammation by Its Possible Self-Regulatory Effect on Epidermal Keratinocytes.
    Funakoshi A; Tatsuno K; Shimauchi T; Fujiyama T; Ito T; Tokura Y
    J Immunol; 2019 May; 202(9):2609-2615. PubMed ID: 30902899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes.
    Christmann C; Zenker S; Martens L; Hübner J; Loser K; Vogl T; Roth J
    Front Immunol; 2020; 11():599947. PubMed ID: 33643287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
    Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
    J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.
    Stjernholm T; Ommen P; Langkilde A; Johansen C; Iversen L; Rosada C; Stenderup K
    Exp Dermatol; 2017 Apr; 26(4):338-345. PubMed ID: 27488462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
    Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
    J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
    Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
    Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17.
    Lin ZM; Ma M; Li H; Qi Q; Liu YT; Yan YX; Shen YF; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
    Pharmacol Res; 2018 Mar; 129():443-452. PubMed ID: 29155016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response.
    Chen Z; Hu Y; Gong Y; Zhang X; Cui L; Chen R; Yu Y; Yu Q; Chen Y; Diao H; Chen J; Wang Y; Shi Y
    Immunology; 2020 Aug; 160(4):382-392. PubMed ID: 32306382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.